Delparantag

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameDelparantag
Drug Alias Name德帕他格delparantagum地帕兰他Delparantag pentahydrochloridePMX-60056
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeparin antagonists
TargetsHeparin
Therapy Area/IndicationsCoronary Artery DiseaseCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCellceutix Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPolymedix Inc
Active IndicationsN/A
Inactive IndicationsCoronary Artery DiseaseCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksKEGG